Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 20.31% is 33% above its 5-year average of 15.31%, near the high end of its 5-year range (11.41%–20.46%).
8.06% above its 12-month average of 18.80%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
20.31%
RETURN ON EQUITY (ROE) AVG TTM
18.80%
RETURN ON EQUITY (ROE) AVG 3Y
15.17%
RETURN ON EQUITY (ROE) AVG 5Y
15.31%
RETURN ON EQUITY (ROE) AVG 10Y
15.25%
RETURN ON EQUITY (ROE) AVG 15Y
15.68%
RETURN ON EQUITY (ROE) AVG 20Y
15.38%
CURRENT VS TTM AVG
+8.06%
CURRENT VS 3Y AVG
+33.90%
CURRENT VS 5Y AVG
+32.62%
CURRENT VS 10Y AVG
+33.19%
CURRENT VS 15Y AVG
+29.51%
CURRENT VS 20Y AVG
+32.02%
SECTOR MEDIAN · HEALTHCARE
13.38%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+51.79%
vs the sector median at left
Universal Health Services, Inc.
Market Cap
$10.21B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$10.16B
Return on Equity (ROE)
12.09%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.15B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.02B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$9.76B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
Market Cap
$9.59B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$11.30B
Return on Equity (ROE)
5.25%
TTM Avg
5.98%
3Y Avg
10.62%
5Y Avg
11.34%
Market Cap
$11.45B
Return on Equity (ROE)
-114.70%
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$12.39B
Return on Equity (ROE)
9771.59%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Universal Health Services, Inc. (UHS) | $10.21B | 20.31% | 18.80% | 15.17% | 15.31% |
| Henry Schein, Inc. (HSIC)vs › | $10.16B | 12.09% | 11.88% | 12.69% | 13.50% |
| Molina Healthcare, Inc. (MOH)vs › | $10.15B | -0.17% | 18.91% | 22.60% | 24.60% |
| Insulet Corp. (PODD)vs › | $10.02B | 26.39% | 25.41% | 19.99% | 14.02% |
| Tempus AI, Inc. (TEM)vs › | $9.76B | -57.18% | -651.33% | -315.37% | -198.08% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.59B | 3.10% | -8.94% | -15.72% | 1.14% |
| Bio-Techne Corporation (TECH)vs › | $11.30B | 5.25% | 5.98% | 10.62% | 11.34% |
| DaVita Inc. (DVA)vs › | $11.45B | -114.70% | 329.18% | 200.63% | 164.66% |
| Align Technology, Inc. (ALGN)vs › | $12.39B | 9771.59% | 10.54% | 10.84% | 19.93% |
| Revvity, Inc. (RVTY)vs › | $12.90B | 3.29% | 3.59% | 3.35% | 7.68% |
ROE
20.3%
ROA
9.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 20.46% |
| 2024-12-31 | 17.13% |
| 2023-12-31 | 11.67% |
| 2022-12-31 | 11.41% |
| 2021-12-31 | 16.28% |
| 2020-12-31 | 14.94% |
| 2019-12-31 | 14.80% |
| 2018-12-31 | 14.47% |
| 2017-12-31 | 15.08% |
| 2016-12-31 | 15.49% |
| 2015-12-31 | 16.01% |
| 2014-12-31 | 14.60% |
| 2013-12-31 | 15.71% |
| 2012-12-31 | 16.34% |
| 2011-12-31 | 17.34% |
| 2010-12-31 | 11.63% |
| 2009-12-31 | 14.87% |
| 2008-12-31 | 12.91% |
| 2007-12-31 | 11.23% |
| 2006-12-31 | 18.50% |
| 2005-12-31 | 19.99% |
| 2004-12-31 | 13.89% |
| 2003-12-31 | 18.27% |
| 2002-12-31 | 19.11% |
| 2001-12-31 | 12.35% |
| 2000-12-31 | 13.03% |
| 1999-12-31 | 12.13% |
| 1998-12-31 | 12.70% |
| 1997-12-31 | 12.78% |
| 1996-12-31 | 11.19% |
